President and CEO of Gilead Sciences Inc (GILD, Financial) John F Milligan sold 70,000 shares of GILD on 09/06/2016 at an average price of $77.74 a share. The total sale was $5.4 million.
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors. Gilead Sciences Inc has a market cap of $104.19 billion; its shares were traded at around $78.95 with a P/E ratio of 6.94 and P/S ratio of 3.54. The dividend yield of Gilead Sciences Inc stocks is 2.23%. Gilead Sciences Inc had an annual average EBITDA growth of 45.90% over the past 5 years.
CEO Recent Trades:
- President and CEO John F Milligan sold 70,000 shares of GILD stock on 09/06/2016 at the average price of $77.74. The price of the stock has increased by 1.56% since.
Directors and Officers Recent Trades:
- Executive Chairman John C Martin sold 100,000 shares of GILD stock on 09/01/2016 at the average price of $77.48. The price of the stock has increased by 1.9% since.
- Director Kevin E Lofton sold 3,500 shares of GILD stock on 08/24/2016 at the average price of $81.97. The price of the stock has decreased by 3.68% since.
For the complete insider trading history of GILD, click here
.
